Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
A randomized controlled study is conducted on patients with histological stage III colorectal
cancer assigned to postoperative adjuvant therapy of uracil-tegafur plus leucovorin (UFT+LV),
UFT+LV / UFT, or UFT+LV+PSK / UFT+PSK. The usefulness of the three regimens was evaluated by
comparing the disease-free survival rate, overall survival rate, incidence and severity of
adverse event, and quality of life.